ILIAS Biologics, a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).A patent for ILIAS's exosome engineering was...
Read More »Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes
Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that the United States Patent and Trademark Office has granted U.S. Patent Number 9,707,333 (the ‘333 Patent), entitled “EXTRACORPOREAL REMOVAL ...
Read More »Regeneus Ltd US Patent Allowed for Sygenus Secretions Technology for Acne
Regeneus, a clinical-stage regenerative medicine company, today announced that the United States Patent Office has issued a notice of allowance for a patent covering the composition, manufacture and use of the secretion stem cell technology platform, known as Sygenus, to treat ...
Read More »Biocept Awarded U.S. Patent with Broad Claims for Antibody Capture of Targets of Interest on Any Solid Surface Including CTCs and Exosomes Shed by Solid Tumors into Blood
Company’s intellectual property portfolio now features 20 issued patents protecting its proprietary liquid biopsy platform technology Biocept, Inc. a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer ...
Read More »Biocept (BIOC) Granted Additional Patent in Japan for ‘Devices & Methods of Cell Capture and Analysis’
Biocept, Inc. announces that it has been awarded Japanese Patent No. 6081434 entitled,. The issued patent covers the use of antibodies for the capture of any target of interest from any sample type on a device surface. This includes CTCs, ...
Read More »New Patent Application Published – Diagnostic Test for Early Stage Cancer
Disclosed are methods of identifying tumor-derived exosomes as an early cancer diagnostic, as well as for staging, Publication number WO2016201064 A1 Publication type Application Application number PCT/US2016/036629 Publication date Dec 15, 2016 Filing date Jun 9, 2016 Priority date Jun ...
Read More »Biocept Awarded Patent in Australia for the Use of Antibodies in Microchannels to Capture Circulating Tumor Cells and Other Rare Cells
Biocept further expands its global patent estate for capturing and detecting cells that are in very low abundance and that can provide important molecular information from biological fluids Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests ...
Read More »Creative Medical Technology Holdings Files Patent on AmnioStem Exosome Stroke Therapy
Creative Medical Technology Holdings (the “Company”) (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled “Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof.” The patent application covers the use of the Company’s ...
Read More »New Patent Granted – Monoclonal antibody for detecting exosomes
The present invention relates to a set of antibodies for detecting an exosome. More particularly, the present invention relates to a monoclonal antibody against a particular antigen (CD9, CD63, CD81) on an exosomal surface or an antibody fragment thereof, a ...
Read More »Exosome Capture Patent Issued
SAN DIEGO, June 14, 2016 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), announced today that U.S. Patent Number 9,364,601 (the “601 Patent”), related to methods for capturing an exosome from a patient, has been issued to the Company by the ...
Read More »